Design Therapeutics Inc
NASDAQ:DSGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Design Therapeutics Inc
NASDAQ:DSGN
|
US |
|
BYC Co Ltd
KRX:001460
|
KR |
|
F
|
FN Republic Co Ltd
KOSDAQ:064090
|
KR |
|
Uni-President China Holdings Ltd
HKEX:220
|
CN |
|
H
|
Hydrotek PCL
SET:HYDRO
|
TH |
|
Humm Group Ltd
ASX:HUM
|
AU |
|
BEST Inc
NYSE:BEST
|
CN |
|
S
|
Surapon Foods PCL
SET:SSF
|
TH |
|
S
|
Sapphire Corporation Ltd
SGX:BRD
|
SG |
|
AMOS Group Ltd
SGX:49B
|
SG |
|
Aeffe SpA
MIL:AEF
|
IT |
Wall Street
Price Targets
DSGN Price Targets Summary
Design Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
DSGN
is 14.96 USD
with a low forecast of 12.12 USD and a high forecast of 18.9 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is DSGN's stock price target?
Price Target
14.96
USD
According to Wall Street analysts, the average 1-year price target for
DSGN
is 14.96 USD
with a low forecast of 12.12 USD and a high forecast of 18.9 USD.